Skip to main content

Bruce Campbell is president and portfolio manager, Campbell, Lee & Ross. His focus is on Canadian large caps.

Top Picks:

Merus Labs (MSL.TO)

Story continues below advertisement

Merus Labs is a specialty pharma company that is focused on acquiring prescription drug products with the potential for creating value over and above the purchase price. They will do this by capitalizing on strategic growth opportunities while growing product sales. They have the combination of enhanced critical mass, cash in the bank from a recent issue and new management. Recent purchases in the $2.80-2.95 last week.

Crescent Point Energy (CPG.TO)

The recent purchase of Legacy will be 3-4 per cent accretive to cash flow and will lower the payout ratio. The $600-million equity issue to pay for it has pressured the stock and provides a short-term chance to buy the stock near a 10-per-cent yield. Their hedges are still meaningful and we believe they will show excellent production and cash flow growth this year. Purchases last week in the low 28's

Element Financial (EFN.TO)

Management has a track-record of executing on acquisitions. We have to believe that they will make full use of the capital that they have raised in advance. They are rumoured to be buyers of the GE fleet assets and accordingly we see potential upside relative to where the shares are trading today. Based on a package deal from GE, including fleet and railcar assets the upside is roughly 25 per cent to $23. That assumes a similar valuation to the current one. Purchases last month in the $16.75 range.

Past Picks: March 12, 2014

Bellatrix Exploration (BXE.TO)

Story continues below advertisement

Then: $9.32; Now: $3.61 -61.27%; Total Return: -61.27%

Agrium (AGU.TO)

Then: $99.03; Now: $129.56 +30.83%; Total Return: +35.06%

Element Financial (EFN.TO)

Then: $12.83; Now: $19.05 +48.48%; Total Return: +48.48%

Total Return Average: +7.42%

Story continues below advertisement

Market outlook:

Equity markets over the past few weeks are stuck in a sideways pattern and lower summer volumes will continue that trend. There continues to be a buy-on-dip mentality and is well entrenched as many investors fear missing out on another leg higher, with increased M&A activity providing an underlying bid to stocks. On the opposite, worries that the equity market is overbought, overvalued and a big correction is overdue are capping the market upside. The alternatives continue to be unattractive and we believe that, albeit with heightened volatility, the markets will grind their way a bit higher into the fall. It does become more of a stock pickers market now, growth is at a premium with the slow upside for GDP environment. Look to healthcare, technology and non-bank financials as places for undervalued earnings upside.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter